199 related articles for article (PubMed ID: 34094960)
1. METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression.
Chen X; Huang L; Yang T; Xu J; Zhang C; Deng Z; Yang X; Liu N; Chen S; Lin S
Front Oncol; 2021; 11():667451. PubMed ID: 34094960
[TBL] [Abstract][Full Text] [Related]
2. METTL3-mediated m
Han H; Yang C; Zhang S; Cheng M; Guo S; Zhu Y; Ma J; Liang Y; Wang L; Zheng S; Wang Z; Chen D; Jiang YZ; Lin S
Mol Ther Nucleic Acids; 2021 Dec; 26():333-346. PubMed ID: 34513313
[TBL] [Abstract][Full Text] [Related]
3. METTL3 Facilitates Tumor Progression by COL12A1/MAPK Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Li J; Li Z; Xu Y; Huang C; Shan B
J Cancer; 2022; 13(6):1972-1984. PubMed ID: 35399719
[No Abstract] [Full Text] [Related]
4. The M6A methyltransferase METTL3 regulates proliferation in esophageal squamous cell carcinoma.
Zou J; Zhong X; Zhou X; Xie Q; Zhao Z; Guo X; Duan Y
Biochem Biophys Res Commun; 2021 Nov; 580():48-55. PubMed ID: 34624569
[TBL] [Abstract][Full Text] [Related]
5. METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m
Zhao W; Cui Y; Liu L; Ma X; Qi X; Wang Y; Liu Z; Ma S; Liu J; Wu J
Mol Ther Nucleic Acids; 2020 Jun; 20():1-12. PubMed ID: 32145676
[TBL] [Abstract][Full Text] [Related]
6. METTL3/m
Ge F; Li Z; Hu J; Pu Y; Zhao F; Kong L
Front Pharmacol; 2022; 13():1002565. PubMed ID: 36386128
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3.
Liao L; He Y; Li SJ; Zhang GG; Yu W; Yang J; Huang ZJ; Zheng CC; He QY; Li Y; Li B
Cancer Res; 2022 Jul; 82(13):2444-2457. PubMed ID: 35507004
[TBL] [Abstract][Full Text] [Related]
8. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
[TBL] [Abstract][Full Text] [Related]
9. Silencing of methyltransferase-like 3 inhibits oesophageal squamous cell carcinoma.
Hu W; Liu W; Liang H; Zhang C; Zou M; Zou B
Exp Ther Med; 2020 Dec; 20(6):138. PubMed ID: 33082869
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
Xia TL; Yan SM; Yuan L; Zeng MS
Cancer Manag Res; 2020; 12():5729-5737. PubMed ID: 32765076
[TBL] [Abstract][Full Text] [Related]
11. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
12. METTL3-mediated upregulation of FAM135B promotes EMT of esophageal squamous cell carcinoma via regulating the Wnt/β-catenin pathway.
Zhang T; Yi W; Dong DZ; Ren ZY; Zhang Y; Du F
Am J Physiol Cell Physiol; 2024 Jun; ():. PubMed ID: 38881420
[TBL] [Abstract][Full Text] [Related]
13.
Zhou Y; Guo S; Li Y; Chen F; Wu Y; Xiao Y; An J
Front Oncol; 2022; 12():824190. PubMed ID: 35574315
[TBL] [Abstract][Full Text] [Related]
14. The METTL3-m
Qiu Y; Tian Z; Miao TY; Shen L; Chen J; Li PF; Zhu ZX; Zhu ZF; Wu WJ; Xu X; Shen WG
Gene; 2024 May; 908():148281. PubMed ID: 38360124
[TBL] [Abstract][Full Text] [Related]
15. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.
Guo YQ; Wang Q; Wang JG; Gu YJ; Song PP; Wang SY; Qian XY; Gao X
Exp Hematol Oncol; 2022 Mar; 11(1):14. PubMed ID: 35287752
[TBL] [Abstract][Full Text] [Related]
16. m
Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
[TBL] [Abstract][Full Text] [Related]
17. METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway.
Yang DD; Chen ZH; Yu K; Lu JH; Wu QN; Wang Y; Ju HQ; Xu RH; Liu ZX; Zeng ZL
Front Oncol; 2020; 10():115. PubMed ID: 32175271
[TBL] [Abstract][Full Text] [Related]
18. METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10.
Cai J; Cui Z; Zhou J; Zhang B; Lu R; Ding Y; Hu H
Cancer Cell Int; 2022 Dec; 22(1):385. PubMed ID: 36476503
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
20. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.
Peng W; Li J; Chen R; Gu Q; Yang P; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y
J Exp Clin Cancer Res; 2019 Sep; 38(1):393. PubMed ID: 31492150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
